For the many Australians living with osteoarthritis pain and stiffness, the conventional pathway of physiotherapy, anti-inflammatory medication, and eventual joint replacement often feels inadequate. Regenerative osteoarthritis treatment targets the underlying cartilage degeneration and joint inflammation, offering a non-surgical alternative. Our Chiang Mai clinic provides Australian patients with evidence-based regenerative joint treatment and structured aftercare coordination with your local healthcare providers.
Regenerative osteoarthritis treatment targets the underlying cartilage degeneration and joint inflammation that drive osteoarthritis progression. Protocols may include PRP (platelet-rich plasma), stem cell therapy, and biological growth factors delivered directly to the affected joint under imaging guidance. Treatment begins with comprehensive joint assessment including imaging review, followed by a tailored programme combining one or more regenerative approaches based on the severity and location of joint degeneration. For a comprehensive understanding of the science, evidence, and treatment process, visit our full Osteoarthritis Treatment page.
Australian patients choose regenerative osteoarthritis treatment because it addresses the underlying joint degeneration rather than simply managing symptoms with medication. The non-surgical approach means shorter recovery, no hospital admission, and the ability to resume daily activities within days rather than weeks. Treatment costs are substantially lower than domestic private options, and English-speaking staff ensure clear communication about your joint condition and treatment plan. Rehabilitation programmes are designed for handover to your local physiotherapist.
Access to advanced regenerative joint therapies is limited under TGA regulations. Thailand offers a broader range of protocols.
Three to seven days in Chiang Mai.
Yes. We provide full treatment records and imaging for your specialist.
Yes, bilateral treatment can be performed during the same visit to Chiang Mai. Your clinician will assess both sides and design a treatment plan accordingly.
A programme is provided for continuation with your Australian physiotherapist.
Treatment in Thailand is typically a fraction of the cost of joint replacement in Australia.
No. The Pharmaceutical Benefits Scheme (PBS) does not cover regenerative joint therapies such as PRP or stem cell-based treatments. These are considered elective and must be paid out-of-pocket, making treatment in Thailand even more cost-effective for Australian patients.
The TGA classifies many regenerative joint therapies as biological medicines requiring formal approval. Most advanced regenerative protocols for osteoarthritis are not listed on the ARTG, limiting their availability in Australian orthopaedic clinics.
Most Australian private health insurers do not cover regenerative joint therapies. Some may cover the initial orthopaedic consultation or diagnostic imaging. Check with your insurer regarding overseas treatment provisions in your policy.